Kempen Capital Management N.V. Abbott Laboratories Transaction History
Kempen Capital Management N.V.
- $9.59 Billion
- Q3 2024
A detailed history of Kempen Capital Management N.V. transactions in Abbott Laboratories stock. As of the latest transaction made, Kempen Capital Management N.V. holds 47,257 shares of ABT stock, worth $5.48 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
47,257
Previous 43,885
7.68%
Holding current value
$5.48 Million
Previous $4.56 Million
18.14%
% of portfolio
0.06%
Previous 0.05%
Shares
13 transactions
Others Institutions Holding ABT
# of Institutions
3,187Shares Held
1.3BCall Options Held
8.74MPut Options Held
8.08M-
Vanguard Group Inc Valley Forge, PA168MShares$19.5 Billion0.35% of portfolio
-
Black Rock Inc. New York, NY131MShares$15.2 Billion0.31% of portfolio
-
State Street Corp Boston, MA76.7MShares$8.89 Billion0.36% of portfolio
-
Capital International Investors Los Angeles, CA65.7MShares$7.62 Billion1.49% of portfolio
-
Capital Research Global Investors Los Angeles, CA53.3MShares$6.18 Billion1.31% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $203B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...